873955-82-9 Usage
1H-Indole-5-carbonitrile
The compound has an indole ring with a cyano group (carbon nitrile) attached to the 5-position.
3-(2-ethoxyphenyl)-2,3-dihydro
The compound has a 2-ethoxyphenyl substituent on the 3-position of the indole ring, and the molecule is a dihydro derivative.
3-hydroxy-2-oxo
The compound has a hydroxy group and an oxo group (carbonyl group) on the 3-position of the indole ring.
Vilazodone
The compound is also known as Vilazodone, which is a medication used to treat depression.
Serotonin reuptake inhibitor
Vilazodone works as a serotonin reuptake inhibitor, which increases the levels of serotonin in the brain and helps alleviate symptoms of depression.
Partial agonist of the serotonin 5-HT1A receptor
Vilazodone also acts as a partial agonist of the serotonin 5-HT1A receptor, which may contribute to its therapeutic effects.
Oral tablet
Vilazodone is available as an oral tablet, which makes it convenient for patients to take.
Minimal side effects
In clinical trials, Vilazodone has been shown to be well-tolerated with minimal side effects, making it a safe and effective treatment option for depression.
Check Digit Verification of cas no
The CAS Registry Mumber 873955-82-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,3,9,5 and 5 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 873955-82:
(8*8)+(7*7)+(6*3)+(5*9)+(4*5)+(3*5)+(2*8)+(1*2)=229
229 % 10 = 9
So 873955-82-9 is a valid CAS Registry Number.
873955-82-9Relevant academic research and scientific papers
SUBSTITUTED OXINDOL DERIVATIVES AND MEDICAMENTS CONTAINING THE SAME
-
Page/Page column 110-111, (2008/06/13)
The invention relates to novel oxindol derivatives of general formula (1) wherein the substituents A, B, R1, R2 and R3 have the designations cited in patent claim 1, and to medicaments containing said derivatives for the prophylaxis and/or treatment of vasopressin-dependent or oxytocin-dependent diseases.
SUBSTITUTED OXINDOLE DERIVATIVES, MEDICAMENTS CONTAINING THE LATTER AND USE THEREOF
-
Page/Page column 41, (2008/06/13)
The invention relates to novel oxindole derivatives of general formula (I), in which the substituents A, B, R1, R2 and R3 are defined as cited in claim 1, to medicaments containing said derivatives and to the use of the la
SUBSTITUTED OXINDOLE DERIVATIVES, MEDICAMENTS CONTAINING THE LATTER AND USE THEREOF
-
Page/Page column 38, (2008/06/13)
The invention relates to novel oxindole derivatives of general formula (I), in which the substituents R1, R2, R3, Y1, Y2, m, n, W, X, B and Z are defined as cited in claim 1, to medicaments containing said derivatives and to the use of the latter for the prophylaxis and/or treatment of vasopressin-dependent and/or oxytocin-dependent diseases.
